Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Operating Expenses | 4,591 | 2,476 | 5,248 | 2,663 | 1,754 |
Operating Income | -4,591 | -2,476 | -5,248 | -2,663 | -1,754 |
Other Income | 34 | 57 | 333 | 297 | -213 |
Pre-tax Income | -4,557 | -2,419 | -4,915 | -2,366 | -1,967 |
Income Tax | 6 | -10 | 41 | -2,515 | 201 |
Net Income Continuous | -4,563 | -2,409 | -4,956 | 149 | -2,168 |
Net Income Extraordinary | N/A | N/A | N/A | 4,428 | N/A |
Net Income | $-4,563 | $-2,409 | $-4,956 | $4,577 | $-2,168 |
EPS Basic Total Ops | -1,804.18 | -946.09 | 87,766.77 | 4,444.44 | -54,587.45 |
EPS Basic Continuous Ops | -1,808.61 | -955.70 | 60,298.03 | 159.37 | -40,151.82 |
EPS Diluted Total Ops | -1,804.18 | -946.09 | 87,766.77 | 4,444.44 | -54,587.45 |
EPS Diluted Continuous Ops | -1,808.61 | -955.70 | 60,298.03 | 159.37 | -40,151.82 |
EBITDA(a) | $-4,576 | $-2,467 | $-5,208 | $-2,642 | $-1,740 |